A randomised trial of concurrent cediranib [AZD2171] (with platinum-based chemotherapy) and maintenance cediranib in women with platinum-sensitive relapsed ovarian cancer.
Trial Number
NCT00532194 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Recurrent Ovarian
Lead Cooperative Group
Participating Groups
ANZGOG
CCTG
GEICO